menu
    • menu

    Company profile for RubrYc Therapeutics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RubrYc Therapeutics, Inc., is a biotechnology company applying proprietary machine-learning and computational biology solutions to discover epitope-selective biotherapeutics. Inspired by recent advances in molecular library synthesis, massively parallel screening and computing, RubrYc is forging a new path for information-driven discovery of therapeutic antibodies. Founded in 2017, RubrYc Therapeutics, Inc. emerged as the ...
    RubrYc Therapeutics, Inc., is a biotechnology company applying proprietary machine-learning and computational biology solutions to discover epitope-selective biotherapeutics. Inspired by recent advances in molecular library synthesis, massively parallel screening and computing, RubrYc is forging a new path for information-driven discovery of therapeutic antibodies. Founded in 2017, RubrYc Therapeutics, Inc. emerged as the exclusive biotherapeutic partner of immunomics leader HealthTell. In April 2018, RubrYc Therapeutics, Inc. spun out of HealthTell

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RubrYc TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    733 Industrial Rd San Carlos, CA 94070
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rubryc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/linkedin-com-company-rubryc-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Texas CDMO is cutting 60% of staff as focus shifts to drug discovery
    Texas CDMO is cutting 60% of staff as focus shifts to drug discovery

    03 Nov 2022

    // Zachary Brennan ENDPTS

    https://endpts.com/texas-cdmo-is-cutting-60-of-staff-as-focus-shifts-to-drug-discovery-in-house-candidates/

    Zachary Brennan ENDPTS
    03 Nov 2022
    Share Share
    CDMO makes an AI and drug discovery play in latest, small-time acquisition
    CDMO makes an AI and drug discovery play in latest, small-time acquisition

    22 Sep 2022

    // Tyler Patchen ENDPTS

    https://endpts.com/cdmo-makes-an-ai-and-drug-discovery-play-in-latest-small-time-acquisition/

    Tyler Patchen ENDPTS
    22 Sep 2022
    Share Share
    iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline
    iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

    21 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/21/2520179/0/en/iBio-Acquires-RubrYc-Therapeutics-AI-Drug-Discovery-Platform-and-Pipeline.html

    GLOBENEWSWIRE
    21 Sep 2022
    Share Share
    RubrYc Therapeutics Announces Series A2 Preferred Share Funding
    RubrYc Therapeutics Announces Series A2 Preferred Share Funding

    25 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210825005880/fr

    BUSINESSWIRE
    25 Aug 2021
    Share Share
    RubrYc Announces a Research Collaboration and License Option Agreement
    RubrYc Announces a Research Collaboration and License Option Agreement

    14 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210413006012/en

    BUSINESSWIRE
    14 Apr 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search